Cargando…

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

Distant metastasis remains the major cause of morbidity for breast cancer. Individuals with liver or brain metastasis have an extremely poor prognosis and low response rates to anti‐PD‐1/L1 immune checkpoint therapy compared to those with metastasis at other sites. Therefore, it is urgent to investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yutian, Ye, Feng, Kong, Yanan, Hu, Xiaoqian, Deng, Xinpei, Xie, Jindong, Song, Cailu, Ou, Xueqi, Wu, Song, Wu, Linyu, Xie, Yi, Tian, Wenwen, Tang, Yuhui, Wong, Chau‐Wei, Chen, Zhe‐Sheng, Xie, Xinhua, Tang, Hailin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929130/ https://www.ncbi.nlm.nih.gov/pubmed/36529697 http://dx.doi.org/10.1002/advs.202203699

Ejemplares similares

Heterogeneous PD-L1 expression in metastases impacts immunotherapy response
por: Hu, Xiaoqian, et al.
Publicado: (2023)

Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022)

Prognosis and Dissection of Immunosuppressive Microenvironment in Breast Cancer Based on Fatty Acid Metabolism-Related Signature
por: Tang, Yuhui, et al.
Publicado: (2022)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
por: Zheng, Shaoquan, et al.
Publicado: (2022)

Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
por: Xie, Jindong, et al.
Publicado: (2022)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
por: Zou, Yutian, et al.
Publicado: (2022)

Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration
por: Tian, Wenwen, et al.
Publicado: (2023)

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
por: Xie, Jindong, et al.
Publicado: (2022)

The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis
por: Zou, Yutian, et al.
Publicado: (2019)

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
por: Tian, Wenwen, et al.
Publicado: (2023)

Advances in artificial intelligence to predict cancer immunotherapy efficacy
por: Xie, Jindong, et al.
Publicado: (2023)

Recent advances in exosome-based immunotherapy applied to cancer
por: Xie, Jindong, et al.
Publicado: (2023)

Is Acupuncture an Ideal Adjunctive Treatment for Cancer-Related Fatigue? Comment on Choi et al. Acupuncture for Managing Cancer-Related Fatigue in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Cancers 2022, 14, 4419
por: Hu, Xiaoqian, et al.
Publicado: (2022)

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A multidimensional analysis
por: Zou, Yutian, et al.
Publicado: (2020)

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer
por: Wang, Jin, et al.
Publicado: (2017)

Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature
por: Luo, Yongzhou, et al.
Publicado: (2022)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2020)

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
por: Liu, Xiaoping, et al.
Publicado: (2015)

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
por: Liu, Peng, et al.
Publicado: (2016)

circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
por: Ye, Feng, et al.
Publicado: (2019)

miR-200c inhibits breast cancer proliferation by targeting KRAS
por: Song, Cailu, et al.
Publicado: (2015)

Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation
por: Liu, Peng, et al.
Publicado: (2023)

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
por: Wang, Jin, et al.
Publicado: (2019)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Diagnostic and prognostic value of circular RNA CDR1as/ciRS‐7 for solid tumours: A systematic review and meta‐analysis
por: Zou, Yutian, et al.
Publicado: (2020)

High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
por: Song, Cailu, et al.
Publicado: (2016)

Incidence and Survival Outcomes of Breast Cancer with Synchronous Hepatic Metastases: A Population-Based Study
por: Xiao, Weikai, et al.
Publicado: (2018)

Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study
por: Xiao, Weikai, et al.
Publicado: (2018)

Breast‐conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population‐based study
por: Yu, Ping, et al.
Publicado: (2020)

The biogenesis, function and clinical significance of circular RNAs in breast cancer
por: Zeng, Yan, et al.
Publicado: (2022)

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2020)

Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer
por: Xie, Xinhua, et al.
Publicado: (2018)

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
por: Liu, Peng, et al.
Publicado: (2019)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

Hepatitis B virus infection specially increases risk of liver metastasis in breast cancer patients: a propensity-matched analysis
por: Yu, Ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_24amgalkcc9s22lr9qa577ajqj